Gefapixant gives a taste of what may work for unexplained chronic cough

A novel drug may help relieve unexplained chronic cough – but at the expense of taste disorders, according to a study in The Lancet Respiratory Medicine. Results from a phase 2b randomised controlled trial found that gefapixant, a P2X3 receptor antagonist, reduced cough frequency by up to 37% compared to placebo in patients with a ...

Already a member?

Login to keep reading.

© 2021 the limbic